Accueil > Revues > Médecine > European Journal of Dermatology > Texte intégral de l'article
 
      Recherche avancée    Panier    English version 
 
Nouveautés
Catalogue/Recherche
Collections
Toutes les revues
Médecine
European Journal of Dermatology
- Numéro en cours
- Archives
- S'abonner
- Commander un       numéro
- Plus d'infos
Biologie et recherche
Santé publique
Agronomie et Biotech.
Mon compte
Mot de passe oublié ?
Activer mon compte
S'abonner
Licences IP
- Mode d'emploi
- Demande de devis
- Contrat de licence
Commander un numéro
Articles à la carte
Newsletters
Publier chez JLE
Revues
Ouvrages
Espace annonceurs
Droits étrangers
Diffuseurs



 

Texte intégral de l'article
 
  Version imprimable

Common variable immunodeficiency and eosinophilic fasciitis


European Journal of Dermatology. Volume 12, Numéro 1, 73-4, January - February 2002, Cas cliniques


Summary  

Auteur(s) : Mario DI GIOACCHINO, Silvio MASCI, Franco PAOLINI, Nicola VERNA, Domenico ANGELUCCI, Enrico CAVALLUCCI, Roberto PAGANELLI, Section of Allergy, Immunopathology and Occupational Medicine, Department of Medicine and Sciences of Aging, Via dei Vestini, 13, 66013 Chieti Scalo, Italy..

Illustrations

ARTICLE

Eosinophilic fasciitis was described over a quarter of a century ago [1]. It is uncommon in females and in children [2], and the main feature is represented by massive thickening of the subcutaneous fascia, with eosinophil infiltration, resulting in indurative swelling of the skin affecting mainly the arms and legs, and intermittent blood eosinophilia [3]. Symptoms of weakness and pain, and progressive motor limitation are the main complaints referred to by patients. Histological examination of full thickness biopsies reveals the primary pathological alterations as occurring in the fascia and not in the skin. A favourable response to oral corticosteroids has usually been reported [3]. The etiology of this condition is unknown, even if a recent history of excessive physical exertion, febrile flu-like illness or increased ingestion of L-tryptophan have all been postulated as possible causes [3]. The association of immunological defects and eosinophilic fasciitis has been reported, and one case had hypogammaglobulinemia [4]. Here we describe another case of eosinophilic fasciitis occurring in a patient with common variable immunodeficiency (CVI).

Case report

The patient, a 53-year-old female, was admitted to the Dermatology Clinic of the University of Chieti in November 1998, for the development of an infiltrative red-coloured lesion of the skin in the malleolar region of the left foot which slowly enlarged to the medial left leg, with itching and pain. Similar manifestations were found in the right inguinal fold, the right ankle, and the upper right arm, without pain.

In the patient's history there were three successful pregnancies with normal delivery, and an episode of post-partum thrombosis and phlebitis of the left saphena, associated with left lung pleurisy occurring after the third pregnancy. Hysterectomy was performed at the age of 30. At the age of 40, the patient underwent a surgical correction for carpal tunnel syndrome.

Physical examination revealed only enlarged abdomen (the patient was overweight, 73 kg), with pain in right iliac fossa, and brownish indurated cutaneous lesions of the left leg which were biopsied, right inguinal fold, right ankle, and upper right arm. The histology demonstrated a thickened fascia with inflammatory infiltrate, including eosinophils (Fig. 1), without muscle involvement. The infiltrate comprised also lymphocytes and plasma cells. X-ray findings showed obliteration of the left costal sinus due to previous pleurisy. Normal esophageal transit was observed after barium intake. Eosinophils were 524 cells/mul, and serum electrophoresis showed reduced gammaglobulin (466 mg/dl). The patient was then discharged with the diagnosis of eosinophilic fasciitis, and given oral griseofulvin 500 mg and chloroquine 200 mg b.i.d. plus 4 mg methylprednisolone daily.

The patient was readmitted to our hospital in March 1999, showing improvement of the cutaneous indurated lesions, which still persisted on the left shoulder and arm, the left ankle and the medial region of the left leg, and the upper part of the right leg, with induration. All biochemical, hematological and autoantibody tests were normal. At that time, serum immunoglobulin levels were investigated. The results are shown in Table I and demonstrate panhypogammaglobulinemia. These findings were confirmed in January 2000, after the patient had discontinued steroid treatment in June 1999, when gammaglobulins were 390 mg/dl and eosinophils had returned to normal levels (380 cells/mul) (Table I). A diagnosis of CVI was therefore made. Lymphocyte subset study showed repeatedly low B cell numbers (4%, absolute n° 64/mul) and reduced CD4+ T cells (440 and 376/mul in September '99 and January 2000), with reversed CD4/CD8 ratio (0.57 and 0.6, normal value 1.2-1.6). Twelve percent of CD4+ T cells expressed the IL-2R (CD25) and only 2% the CD45RA marker.

Discussion

Both CVI and eosinophilic fasciitis represent uncommon diseases. CVI is a primary immunodeficiency disorder characterized by a variable decrease (two or more standard deviations from the normal mean) of IgG, IgA and/or IgM and heterogeneous clinical features [5]. Its cause is unknown, although both a genetic predisposition and dysregulation of cytokine production have been postulated. The phenotypic defect is a failure in B cell differentiation, inducing reduction of Ig secretion. An accelerated peripheral B cell apoptosis may also be involved in B cell depletion [6]. T cell abnormalities include decrease of lymphocyte proliferation, a defect in the early phase of T cell activation, deficiency of antigen-primed T cells, and reduced production and/or expression of IL-2 and other cytokines [5]. In our patient, CVI was diagnosed by chance observation of persistently low levels of all Ig classes, unrelated to protein loss or immunosuppressive treatment. The diagnosis was made one year after the appearance of eosinophilic fasciitis, which is usually characterized by hypergammaglobulinemia [2-4]. In the skin biopsies, along with eosinophilic infiltrate, plasma cells were also identified, but they could not locally contrast the central failure of B cell differentiation into Ig-producing cells. The presence of B lymphocytes and the reversed CD4/CD8 ratio are other factors described in CVI [5]. Only one case of association between CVI and eosinophilic fasciitis has been previously reported [4], although patients with selective IgA deficiency - a condition often related to CVI - have also been described.

Skin diseases most frequently associated with CVI are granulomatous disorders, such as those due to infections, subcutaneous nodules, erythema nodosum or vasculitic lesions and Raynaud's phenomenon. On the contrary, the association of eosinophilic fasciitis with primary immunodeficiencies is apparently rare, but since both conditions are also rare, an increased rate of simultaneous occurrence can be hypothesized. Our description may prompt others to validate this assumption.

Article accepted on 1/6/01

REFERENCES

1. Shulman LE. Diffuse fasciitis with hypergammaglobulinaemia and eosinophilia, a new syndrome? J Rheumatol 1984; 11: 569-70.

2. Grisanti MW, Moore TL, Osborn TG, Haber PL. Eosinophilic fasciitis in children. Semin Arthritis Rheum 1989; 19: 151-7.

3. Nelson AM. Localized forms of scleroderma, including morphea, linear scleroderma, and eosinophilic fasciitis. Curr Opin Rheumatol 1996; 8: 473-6.

4. Ormerod AD, Grieve JHK, Rennie JAN, Edward N. Eosinophilic fasciitis - a case with hypogammaglobulinaemia. Clin Exp Dermatol 1984; 9: 416-8.

5. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.

6. Guo BC, Saxon AB. B cell lines from a subset of patient with common variable immunodeficiency undergo enhanced apoptosis associated with an increased display of CD95 (Apo-1/fas) diminished CD38 expression, and decreased IgG and IgA production. Cell Immunol 1995; 166: 83-92.


 

Qui sommes-nous ? - Contactez-nous - Conditions d'utilisation - Paiement sécurisé
Actualités - Les congrès
Copyright © 2007 John Libbey Eurotext - Tous droits réservés
[ Informations légales - Powered by Dolomède ]